Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy
Open Access
- 22 April 2026
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 183 (13) , 3866-3884
Abstract
Background and Purpose: The absence of the protein dystrophin in Duchenne muscular dystrophy (DMD) leads to progressive muscle weakness, failing regeneration and deregulation of nitric oxide (NO) signalling. We focused on L‐citrulline, a precursor of L‐arginine, required for NO production in muscle, which is reduced in dystrophic mdx muscle. Experimental Approach: L‐Citrulline was administered (2 mg g −1 die −1 ), through diet, in comparison and/or in combination with prednisolone (1 mg kg −1 , 5 days per week subcutaneously) to 4‐ to 5‐week‐old mdx mice for 8 weeks. Key Results: L‐Citrulline increased the levels of L‐arginine, L‐citrulline and L‐ornithine in plasma and quadriceps of mdx mice. L‐citrulline, alone or plus prednisolone, significantly improved maximal forelimb force in vivo, while ameliorating diaphragm movement amplitude and reducing diaphragm echodensity. In parallel, ex vivo, we detected a significant improvement of diaphragm force and contraction kinetics in mice treated with L‐citrulline alone or in combination with prednisolone. L‐citrulline also restored the expression of genes involved in Ca 2+ handling during contraction ( RyR1 , RyR3 and SERCA ), while reducing the markers of inflammation and fibrosis ( CD68 and TGFβ1 ) and ameliorating mitochondrial biogenesis‐associated genes ( PGC1‐α and MEF2C ). No effect was observed on S‐nitrosylation levels of HDAC2 and on diaphragm and gastrocnemius nNOS gene expression, suggesting a NO‐independent mechanism underlying the positive outcome observed. Conclusions: Our results revealed the ability of L‐citrulline supplementation to ameliorate in vivo and ex vivo function of diaphragm muscle, highlighting novel metabolic and calcium‐related mechanisms of potential clinical interest.Keywords
Funding Information
- Duchenne Parent Project
This publication has 58 references indexed in Scilit:
- Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular DystrophyJAMA Network Open, 2019
- Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 SignalingCell Metabolism, 2019
- Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophyBiochemical Pharmacology, 2018
- Effects of single and combined metformin and l-citrulline supplementation on l-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implicationsAmino Acids, 2018
- l -Citrulline ameliorates cerebral blood flow during cortical spreading depression in rats: Involvement of nitric oxide- and prostanoids-mediated pathwayJournal of Pharmacological Sciences, 2017
- The l-arginine/NO pathway and homoarginine are altered in Duchenne muscular dystrophy and improved by glucocorticoidsAmino Acids, 2015
- Nitric oxide reverses prednisolone‐induced inactivation of muscle satellite cellsMuscle & Nerve, 2007
- Selective expression of the type 3 isoform of ryanodine receptor Ca2+ release channel (RyR3) in a subset of slow fibers in diaphragm and cephalic muscles of adult rabbitsBiochemical and Biophysical Research Communications, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Dystrophin: The protein product of the duchenne muscular dystrophy locusCell, 1987